Current Use of GLP-1 Receptor Agonists in Type 2 Diabetes Treatment
In round one of their discussion on GLP-1 receptor agonists in Type 2 Diabetes, Robert Gabbay, MD, PhD, and Robert Kushner, MD, discuss the current usage of GLP-1 in treatment.
Moderator Robert Gabbay, MD, conducts a series of investigative interviews with a fellow healthcare professional, exploring each aspect of Type 2 Diabetes from a new lens. A new topic will publish each month.
